
















Systolic dysfunction in infarcted mice does not necessarily lead to heart failure: 
need to refine preclinical models 
Villalba-Orero, infarcted mice do not over signs of heart failure. 
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Heart failure (HF) is a major cause of death and hospitalization worldwide. Despite  
advances in reducing mortality, prognosis remains poor and prevalence has reached  
epidemic proportions. The limitations of available preclinical models represent a major  
hurdle in the development of new therapies. Myocardial infarction (MI) is a main cause  
of HF in humans and mouse models of MI are often used to study HF mechanisms and  
experimental treatments. We investigated whether MI in mice constitutes an appropriate  
model of HF. Permanent ligation of the left coronary artery induced severe and persistent  
systolic dysfunction and ventricular dilatation. Mouse follow up for 10 months showed  
no significant evidence of lung congestion or other pulmonary defects associated with  
HF. No difference was observed in the capacity of infarcted mice to exercise compared  
to control animals. These results indicate that severe cardiac dysfunction in mice is not  
sufficient to demonstrate the presence of HF.  
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Heart failure (HF) is a major cause of death and disability. Despite advances, prognosis  
remains poor, and the underlying mechanisms are not completely understood. Recent  
reports highlight methodological shortcomings in HF evaluation in preclinical studies,  
which preclude the development of new treatments[1, 2]. HF is a complex syndrome,  
characterized by fluid retention, breathlessness and tiredness[2]. In mice, symptoms are  
difficult to evaluate and the presence of HF is often assumed based on cardiac  
dysfunction. Myocardial infarction (MI) is a major cause of HF in humans and around  
25% of patients develop HF within the first 4 years after a first MI[3]. Therefore, MI is  
often used as a model of HF in mice [1]. Systolic dysfunction in mice after infarction is  
well proven, however, HF is seldom assessed. Here we investigated whether MI in mice  
actually results in the development of HF.  
Seventeen 20-week-old male C57BL/6 mice underwent permanent occlusion of the left  
descending anterior coronary artery (MI group) and eight unoperated mice were used as  
controls (Ctl group). Cardiac function was analyzed by echocardiography. Only mice  
with left ventricular ejection fraction (LVEF) <45% and at least two akinetic cardiac  
segments at day 5 post-infarction were retained (n=13). Animals were analyzed every  
month for 10 months. Mouse lung ultrasound (MoLUS) score was used to evaluate  
pulmonary changes associated to HF[4]. Since fatigue is one of the symptoms used to  
diagnose HF in humans, we used metabolic cages and a treadmill to determine exercise  
tolerance post-infarction.  
Myocardial infarction caused a sustained decrease in LVEF (Fig 1a). Similarly, infarct  
size, and the wall motion score index did not change significantly over time in the MI  
group (Fig. 1b, 1c). Infarcted mice showed progressive left ventricular dilatation, as  
observed by the increase in left ventricle end-diastolic volume (Fig. 1d). Despite evident  
cardiac dysfunction and remodeling, MoLUS analysis revealed only minor changes  
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associated with pulmonary congestion, edema or effusion, and none of the infarcted mice 
reached a MoLUS score >10.5, which is indicative of HF (Fig. 1e) [4]. Accordingly, the 
lung water content was not significantly increased in MI mice 10 months post-infarction 
(Fig. 1f).  
Infarcted and control mice showed similar food and water consumption (Ctl: 11.27±1.84 
g, MI: 13.88±9.98 g; Ctl: 9.19±1.47 ml, MI: 8.23±1.80 ml; respectively) and similar O2 
and CO2 exchange (Ctl: 19.57±2.67 ml/min/kg, MI: 19.58±2.11 ml/min/kg; Ctl: 
18.13±2.60 ml/min/kg, MI: 17.84±2.04 ml/min/kg; respectively). Voluntary activity and 
rearing showed no differences between groups. Compared to young uninjured mice, 
distance run on the treadmill was lower in both, control and infarcted mice, likely due to 
age. Infarcted mice showed no decrease in exercise capacity (Fig. 1g-i).  
In summary, our results indicate that although MI causes systolic dysfunction in mice, it 
does not actually lead to HF, at least within the first ten months post-infarction. While the 
mouse MI is a valuable tool to study heart repair, remodeling and dysfunction[2], it does 
not replicate human HF syndrome. Our results reinforce the need to demonstrate the 
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Long-term physiological parameters of mice following myocardial infarction. (a-d) : 
Control (Ctl) and infarcted (MI) mice were investigated by echocardiography at 1, 6 and 
10 months in order to determine (a) LVEF, (b) infarct size, represented as the number of 
segments affected, (c) wall motion score index, using a 12-segment model scored as 
1:normal; 2: hypokinetic, 3:akinetic, 4:dyskinetic and 5:aneurysmal (WMSI,  dashed line 
indicates basal score) and (d) left ventricular end-diastolic volume (LVEDV). (e) Mouse 
lung ultrasound (MoLUS) was used to assess lung congestion. The dashed line indicates 
a MoLUS score threshold of 10.5, above which HF is considered to be reliable. (f) Lung 
water content in Ctl and MI mice at 10 months post-infarction. (g-i) Spontaneous activity 
and exercise tolerance in Ctl and MI mice 10 months post-infarction as determined by (g) 
locomotor activity, (h) total rearing count and (i) total running capacity (dashed line 
indicates distance run by 4-month old mice, as a reference). ***P< 0.001 compared to the 
Ctl group and ♯P<0.05 compared to previous time points using one-way (b, c) or two-way 
(a, d, e) ANOVA followed by Tukey correction, or unpaired t-test (f-i). 
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